PATENT CLAIM ANALYSIS

Application Number: 16354563
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "600000"]

Abstract:
The disclosure provides nucleic acids, including cDNA, comprising alterations that encode aspartic acid at a position corresponding to position 533 of the human G protein-coupled receptor 156 protein (GPR156). The disclosure also provides isolated and recombinant human GPR156 protein variants that comprise an aspartic acid at a position corresponding to position 533. The change to aspartic acid, and the gene encoding this change, associate with unipolar depression. The disclosure also provides methods for determining whether a subject has or has a risk of developing unipolar depression, based on the identification of such alterations in the gene (DNA or RNA) encoding GPR156.

Claim (Index 35):
The molecular complex according to  claim 29 , wherein the DNA consists of a nucleic acid sequence according to SEQ ID NO:11.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.80952
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15662689', '11750019', '09394264', '13023295', '10870030']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6962473492869851
- 35 USC 102 Novelty (BERT): 0.5455764549689862
- Combined Prediction Score: 0.6811802598551853
- Mean Citation Score: 246.041174
- Max Citation Score: 380.02484
- Similarity Product: 238.9704371557497

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test